BDTX icon

Black Diamond Therapeutics
BDTX

Overview Fund Activity

50 hedge funds and large institutions have $40.6M invested in Black Diamond Therapeutics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-9
Holders Change %
-15.25%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
8
Reduced
17
Closed
9
Calls
$45K
Puts
$1K
Net Calls
+$44K
Net Calls Change
+$71K

Top Buyers

1
EC
EcoR1 Capital
California
+$1.72M
2
Verition Fund Management
Verition Fund Management
Connecticut
+$651K
3
Millennium Management
Millennium Management
New York
+$476K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$79.2K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.71K

Top Sellers

1
BlackRock
BlackRock
New York
-$449K
2
Citadel Advisors
Citadel Advisors
Florida
-$408K
3
KPF
K2 Principal Fund
Ontario, Canada
-$278K
4
Federated Hermes
Federated Hermes
Pennsylvania
-$268K
5
DCM
DAFNA Capital Management
California
-$176K
Name Holding Trade Value Shares
Change 		Shares
Change %
Belvedere Trading
51
Belvedere Trading
Illinois
– -$31.1K -17,295 Closed
Jane Street
52
Jane Street
New York
– -$23.2K -12,914 Closed
UBS Group
53
UBS Group
Switzerland
– -$6.18K -3,433 Closed
BAM
54
Belpointe Asset Management
Nevada
– -$2.16K -1,201 Closed
Citigroup
55
Citigroup
New York
– -$243 -135 Closed
IRC
56
Investors Research Corp
Georgia
– -$54 -30 Closed
1 2
3